SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Alseres Pharmaceuticals
ALSE 0.005000.0%Oct 18 5:00 PM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: JMarcus who wrote (953)3/26/2004 1:55:34 PM
From: tuck   of 975
 
Maybe, finally, some forward motion coming?

>>BOSTON--(BUSINESS WIRE)--March 26, 2004--Boston Life Sciences, Inc. (NASDAQ: BLSI - News) announced that it will hold an investors' conference call on Friday, April 2, 2004 at 10 a.m. EST.

The call will be moderated by Dr. Marc Lanser, the Company's President and Chief Scientific Officer. Dr. Lanser will provide an update on the Company's Special Protocol Assessment for an additional Phase III study for Altropane, the recently filed 10-K, and other matters. Following his report, there will be a question and answer session.

To participate in the conference call, please dial (800) 556-3831 within the U.S. and Canada, or for International callers, dial (972) 512-0694. All participants must enter the following passcode to join in the call: 00653. The conference call will be recorded and may be heard beginning April 2, 2004 at 1:00 pm EST by dialing (888) 746-9011 within the U.S. and Canada, or for International callers, dial (972) 512-0694 and enter the passcode 01457. The audio recording of the call will be available through April 5, 2004 until 11:59 pm EST. <<

Looks like some kind of motion, anyhow.

Cheers, Tuck
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext